scholarly journals Biomaterials Science Can Offer a Valuable Second Opinion on Nature’s Plastic Malady

2022 ◽  
Author(s):  
Bryan D. James ◽  
Mark E. Hahn ◽  
Christopher M. Reddy
Keyword(s):  
Second Opinion

Second opinion verändert die Behandlung von Patientinnen mit Brustkrebs

Praxis ◽  
2007 ◽  
Vol 96 (39) ◽  
pp. 1489-1490
Author(s):  
J. Steurer
Keyword(s):  
Second Opinion

Get a second opinion: Comment on Bleidorn et al. (2019).

2020 ◽  
Vol 75 (5) ◽  
pp. 729-730
Author(s):  
Robert R. McCrae
Keyword(s):  
Second Opinion

Getting a Second Opinion

2002 ◽  
Author(s):  
Stephanie Levin-Gervasi
Keyword(s):  
Second Opinion

Consultation second opinion and risk assessment of donor in the Italian transplanation network

2018 ◽  
Author(s):  
Albino Eccher ◽  
Matteo Brunelli
Keyword(s):  
Risk Assessment ◽  
Second Opinion

scholarly journals Application of a second opinion ultrasound in Breast Imaging Reporting and Data System 4A cases: can immediate biopsy be avoided?

2021 ◽  
Vol 49 (6) ◽  
pp. 030006052110244
Author(s):  
Yantao Cai ◽  
Chenfang Zhu ◽  
Qianqian Chen ◽  
Feng Zhao ◽  
Shanyu Guo
Keyword(s):  
Minimally Invasive ◽  
Predictive Factors ◽  
Breast Imaging ◽  
Protective Factor ◽  
Multivariate Analyses ◽  
Data System ◽  
Second Opinion ◽  
Factors Associated ◽  
Peripheral Location ◽  
Biopsy Rate

Objective The probability of malignancy in women who are diagnosed with a Breast Imaging Reporting and Data System (BI-RADS) 4A score is low. Application of a second opinion ultrasound (SOUS), which is low in cost and minimally invasive, may lower the biopsy rate for patients who fall into this category. This study aimed to apply SOUS to patients with a BI-RADS score of 4A and predict the pathological results of a biopsy. Methods One hundred seventy-eight patients were analyzed. Univariate and multivariate analyses were performed to screen for predictive factors that are associated with malignancy. Categorical alteration of downgraded, unchanged, or upgraded was made after SOUS results. Changes in category were compared with biopsies to determine their predictive value of benignancy or malignancy. Results Independent factors associated with malignancy were age (>50 years), tumor size (≥20 mm), margin (not circumscribed), orientation (not parallel), and peripheral location, and an upgraded categorical alteration from SOUS. Downgraded categorical alterations were associated with benignancy. Conclusions In BI-RADS 4A cases, a biopsy is recommended when independent factors are associated with malignancy. A downgraded result from an SOUS examination is a protective factor, supporting the likelihood of benignancy in these patients.

Providing second-opinion interpretations of pediatric imaging: embracing the call for value-added medicine

2021 ◽  
Vol 51 (4) ◽  
pp. 523-528
Author(s):  
Marla B. K. Sammer ◽  
J. Herman Kan
Keyword(s):  
Value Added ◽  
Second Opinion ◽  
Pediatric Imaging

scholarly journals White coat ceremonies: a second opinion

2002 ◽  
Vol 28 (1) ◽  
pp. 5-6 ◽  
Author(s):  
R M Veatch
Keyword(s):  
White Coat ◽  
Second Opinion

scholarly journals Results of a patient-oriented second opinion program in Germany shows a high discrepancy between initial therapy recommendation and second opinion

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Jan Weyerstraß ◽  
Barbara Prediger ◽  
Edmund Neugebauer ◽  
Dawid Pieper
Keyword(s):  
Initial Therapy ◽  
Second Opinion ◽  
Therapy Recommendation
Sign in / Sign up

Export Citation Format

Share Document